<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03431844</url>
  </required_header>
  <id_info>
    <org_study_id>HN1160</org_study_id>
    <nct_id>NCT03431844</nct_id>
  </id_info>
  <brief_title>Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation</brief_title>
  <official_title>Prospective Clinical Observational Study of Humanin Isoforms in Cardiac Muscle and Blood Plasma and Their Association to Major Complications After Cardiac Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tartu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tartu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North Estonia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Tartu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective of the study is to clarify humanin-like peptide concentration in myocard tissue and&#xD;
      in blood and to study if its concentration level is related to early complication occurrence&#xD;
      and frequency after cardiac operation.&#xD;
&#xD;
      Hypothesis of the study is that previously described elements are related to each other.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data collection: Historical medical and preoperative data, operation data (type of operation&#xD;
      performed and its details), detailed postoperative course (occurrence of complications).&#xD;
&#xD;
      Specimen collection:&#xD;
&#xD;
        -  Tissue sample is taken during the operation from the right atrial appendage of the heart&#xD;
           and the sample is frozen at -80 C.&#xD;
&#xD;
        -  Blood samples are taken just before the operation, one hour after aortic cross-clamp&#xD;
           removal and the next morning after the operation. Samples are processed and blood plasma&#xD;
           is frozen at -80 C.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">August 31, 2019</completion_date>
  <primary_completion_date type="Actual">August 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>30-day all-cause mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major complications: myocardial infarction.</measure>
    <time_frame>30 days</time_frame>
    <description>Diagnosed myocardial infarction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major complications: acute kidney injury.</measure>
    <time_frame>30 days</time_frame>
    <description>Diagnosed acute kidney failure (KDIGO stage).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major complications: stroke.</measure>
    <time_frame>30 days</time_frame>
    <description>Diagnosed stroke.</description>
  </primary_outcome>
  <enrollment type="Actual">106</enrollment>
  <condition>Myocardial Ischemia</condition>
  <condition>Coronary Artery Bypass Surgery</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Right atrial heartmuscle biopsy, blood samples.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients who have a history of ischemic heart disease and who are going to have&#xD;
        an elective on-pump CABG operation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age at least 18 years&#xD;
&#xD;
          -  Ischemic heart disease in medical history&#xD;
&#xD;
          -  Planned on-pump coronary artery bypass graft (CABG) operation&#xD;
&#xD;
          -  Signed informed consent by patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
&#xD;
          -  Planned isolate valve or aortic operation&#xD;
&#xD;
          -  Patient is in another study with an intervention&#xD;
&#xD;
          -  Absence of signed informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Starkopf, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tartu University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Estonia Medical Centre</name>
      <address>
        <city>Tallinn</city>
        <state>Harjumaa</state>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tartu University Hospital</name>
      <address>
        <city>Tartu</city>
        <state>Tartumaa</state>
        <zip>51014</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>January 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2018</study_first_posted>
  <last_update_submitted>August 3, 2020</last_update_submitted>
  <last_update_submitted_qc>August 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Tartu</investigator_affiliation>
    <investigator_full_name>Henery Kroon</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

